Susquehanna International Group, LLP Seres Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,192,749 shares of MCRB stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,192,749
Previous 1,427,700
16.46%
Holding current value
$1.07 Million
Previous $1.03 Million
10.32%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding MCRB
# of Institutions
82Shares Held
40.5MCall Options Held
304KPut Options Held
471K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$20.8 Million3.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.06MShares$5.45 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$1.59 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.39MShares$1.25 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.02MShares$919,7610.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $112M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...